These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7742004)

  • 1. Genetic changes in ovarian cancer.
    Pejovic T
    Ann Med; 1995 Feb; 27(1):73-8. PubMed ID: 7742004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome aberrations in 35 primary ovarian carcinomas.
    Pejovic T; Heim S; Mandahl N; Baldetorp B; Elmfors B; Flodérus UM; Furgyik S; Helm G; Himmelmann A; Willén H
    Genes Chromosomes Cancer; 1992 Jan; 4(1):58-68. PubMed ID: 1377010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenesis in ovarian cancer.
    Børresen AL
    Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic aspects of ovarian cancer.
    Karlan BY; Krakow D
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):105-10. PubMed ID: 8180345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics and molecular genetics of human solid tumours.
    Sahlin P; Stenman G
    Scand J Plast Reconstr Surg Hand Surg; 1995 Jun; 29(2):101-10. PubMed ID: 7569807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Karck U; Kommoss F; du Bois A; Pfleiderer A
    Gynecol Oncol; 1994 Nov; 55(2):198-205. PubMed ID: 7959284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epithelial cancers of the ovary. Recent trends].
    van den Brûle FA; Lambotte R; Castronovo V
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):241-52. PubMed ID: 7622770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.
    Wu R; Connolly DC; Ren X; Fearon ER; Cho KR
    Neoplasia; 1999 Oct; 1(4):311-4. PubMed ID: 10935485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
    Kamiński K; Putowski L; Oleszczuk J
    Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
    Micci F; Weimer J; Haugom L; Skotheim RI; Grunewald R; Abeler VM; Silins I; Lothe RA; Trope CG; Arnold N; Heim S
    Genes Chromosomes Cancer; 2009 Feb; 48(2):184-93. PubMed ID: 18973136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis.
    Tibiletti MG; Bernasconi B; Taborelli M; Facco C; Riva C; Capella C; Franchi M; Binelli G; Acquati F; Taramelli R
    Cancer Genet Cytogenet; 2003 Oct; 146(2):145-53. PubMed ID: 14553949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
    Aunoble B; Sanches R; Didier E; Bignon YJ
    Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic analysis of 52 colorectal carcinomas--non-random aberration pattern and correlation with pathologic parameters.
    Bardi G; Johansson B; Pandis N; Mandahl N; Bak-Jensen E; Lindström C; Törnqvist A; Frederiksen H; Andrén-Sandberg A; Mitelman F
    Int J Cancer; 1993 Sep; 55(3):422-8. PubMed ID: 8375927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
    Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
    Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.
    Stanley LA
    Toxicology; 1995 Feb; 96(3):173-94. PubMed ID: 7900159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(1):130-5. PubMed ID: 15927360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
    Johansson B; Fioretos T; Mitelman F
    Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.